The report highlights Hanmi Pharm's sustainability management performance during the 2018 fiscal year. The company achieved significant growth in its innovative drug pipeline, successfully developed a number of new drugs for the global market, and expanded its market-leading position in South Korea's pharmaceutical industry. The report also highlights the company's commitment to its employees' welfare, including investments in their training and development, as well as its contributions to local communities through social initiatives and donations.
Issuing Company Hanmi Pharm. Co., Ltd.
Report Type Sustainability Report
Report Language EN
Report Filesize 5.83 MB
No. of Pages 54 pages
Reporting periodJanuary 1, 2018-December 31, 2018
Report Edition2
Assurance Provider Korean Standards Association
Reporting Standards GRI; AA1000 Assurance Standard
Materiality Assessmenttrue